Cuba’s most advanced Covid-19 vaccine candidate is scheduled to enter late-stage clinical trials next week, nudging the tiny island nation ever closer to an extraordinary medical achievement that analysts believe will have far reaching consequences throughout the global south. Cuba’s most promising vaccine candidate, of the four it has in development, is called Soberana 02. The […] Read more
Cuba’s most advanced Covid-19 vaccine candidate is scheduled to enter late-stage clinical trials next week, nudging the tiny island nation ever closer to an extraordinary medical achievement that analysts believe will have far reaching consequences throughout the global south. Cuba’s most promising vaccine candidate, of the four it has in development, is called Soberana 02. The […] Read more
AstraZeneca and the University of Oxford are defending the results and methods used in their phase three vaccine trials on the back of criticism from experts in the U.S., stressing the “highest standards” were used and that “additional analysis will be conducted.” AstraZeneca shares are down by around 6% this week after questions were raised over […] Read more
